Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Ethics in pharmaceutical field
Ethics in pharmacy
Ethics in pharmacy
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Ethics in pharmaceutical field
Annotated Bibliography: “Effective Methods of Communication amongst the Pharmaceutical Industry, the Public and All Those in Between” D'Arcy, E., & Moynihan, R. (2009). Can the relationship between doctors and drug companies ever be a healthy one?. International Journal Of Risk & Safety In Medicine, 21(4), 185-191. doi:10.3233/JRS-2009-0481 Is it ethical for a doctor to have a strong affiliation with a drug retailer? This question has raised several concerns. The relationship amongst doctors and drug corporations is the focus of extreme analysis. This article illustrates the views of both side, supporters and reformers. Emma D’Arcy, a medical biochemist, insists that the link between doctors and pharmaceutical companies need to exist for the patients to continue a healthy living. She believes the industries need to collaborate with health care professionals in order to produce effective drugs to treat the patients. Meanwhile some individuals believe the relationship between pharmaceutical corporations and doctors are too close. Ray Moynihan, an award winning health journalist, claims that these existing relationships need to have its’ limitations. The doctor and industry will be the only ones to profit a change does not come. The goal of this source is to give the viewpoints of both sides in regards to doctor and drug companies’ relationship. It also expresses the idea of not eliminating the relationship but improving them. Unlike some of the sources listed here, this source actually shed light on the idea of a healthy doctor/ supplier relationship. This is the only source that gives the objective view of people from both sides. I will use this article to awareness of doctor/pharmaceutical relationship by giving solutions to prev... ... middle of paper ... ...ans have to show their concern by protecting the consumers/patients. This survery illustrates that all forms of advertisements effect the people no matter the circumstances of said people. It shows that advertisements are not only great means of sales but also great methods of educating and informing. This article will help elaborate on my idea that advertisements, if used correctly, can benefit both the industry and the public. The industry will generate more sales which the profit could fund better research and development of new products. The public can benefit from the same advertisements by knowing the products side-effects while self-medicating. This article is reliable because it focus on the responsibility of the industry, the retailers, the doctors, and the public. This responsibility raised the idea of supportive communication between all the individuals.
In order to sustain the market share in this highly competitive industry, the pharmacies have to establish and maintain strong working relationships with PBMs that have power to divest particular clients from a pharmacy by denying reimbursement privileges to their customers. Buyer Power Strong It is not hard to obtain the same drugs from different sources, so the customer loyalty is virtually non-existent and the pharmacies have to try extremely hard to sustain their consumer base. Threats of substitutes Weak There are very few alternatives to drugs. Alternatives are practically limited to traditional medicine.
Dr. John Abramson’s book Overdosed America debunks the myths about the excellence of American medicine. Abramson backs up this claim by closely examining research about medicine, closely examining the unpublished details submitted by drug manufacturers to the FDA, and discovering that the unpublished data does not coincide with the claims made about the safety and effectiveness of commonly used medicines. Abramsons purpose is to point out the flaws of the pharmaceutical industry in order to warn the readers about the credibility of the drugs they are buying. Given the critical yet technical language of the book, Abramson is writing to an audience that may include academic physicians as well as those who want to learn about the corruption of the pharmaceutical industry.
Lyles, Adam. “Direct Marketing of Pharmaceuticals to Consumers.” Annual Review of Public Health, volume 23. 2002. Print.
"In the past two decades or so, health care has been commercialized as never before, and professionalism in medicine seems to be giving way to entrepreneurialism," commented Arnold S. Relman, professor of medicine and social medicine at Harvard Medical School (Wekesser 66). This statement may have a great deal of bearing on reality. The tangled knot of insurers, physicians, drug companies, and hospitals that we call our health system are not as unselfish and focused on the patients' needs as people would like to think. Pharmaceutical companies are particularly ruthless, many of them spending millions of dollars per year to convince doctors to prescribe their drugs and to convince consumers that their specific brand of drug is needed in order to cure their ailments. For instance, they may present symptoms that are perfectly harmless, and lead potential citizens to believe that, because of these symptoms, they are "sick" and in need of medication. In some instances, the pharmaceutical industry in the United States misleads both the public and medical professionals by participating in acts of both deceptive marketing practices and bribery, and therefore does not act within the best interests of the consumers.
DTC advertisements aim to persuade that their possibly less effective drugs work better than other drugs rather than to inform consumers of correct information about drugs. The reason that pharmaceutical companies abuse the power of DTC advertising is because the pharmaceutical industry does not have a strong ethical code for advertising; their sales are so obsessed with profits. To solve this problem, policy makers should prohibit indiscreet DTC advertisements on air and fund more informative services about new drugs so that patients could make clever
Direct-to-consumer prescription drug ads are dangerous and can have serious effects on the health of the general public. In the article “Pros & Cons Arguments: ‘Should prescription drugs be advertised directly to consumers?’”, the pros and cons of the advertising of prescription drugs are compared. The negative aspects of these ads outweigh that of the positives. DTC prescription drug ads misinform patients, promote over-usage, and pressure medical providers. The counter side argues that these ads inform patients, create a positive impact on patient compliance with medication, and cause patients to confront their doctors.
In Melody Peterson’s “Our Daily Meds” , the history of marketing and advertising in the pharmaceutical industry is explored. The first chapter of the book, entitled “Creating disease”, focuses on how major pharmaceutical companies successfully create new ailments that members of the public believe exist. According to Peterson, the success that these drug manufacturers have experienced can be attributed to the malleability of disease, the use of influencial people to promote new drugs and the efficient usage of media outlets.
Pharmaceuticals are arguably one of the most contentious of all goods and services traded in the market. While medicines are as much a necessity as foods and water, they require more technical expertise and official approbation in the manufacture. Above all, they carry a moral weight that most market products do not (The Economist, 2014). This idea of moral can be linked to the recurring debate over whether a good health (which is represented by medicines, in this case) should be considered a basic human right, or just a normal commodity. A large portion of such controversy actually lies in an existence of drug patents: should we promote for longer-lasting patents or should we have their duration shortened?
In America, it has become a battle to earn a high paying job to cope with the expenses of a typical American. It has become even more of a battle for some people to afford medical prescriptions to keep healthy. Health becomes a crucial issue when discussed among people. No matter what, at one point or another, everyone is going to stand as a victim of the pharmaceutical industry. The bottom line is Americans are paying excessive amounts of money for medical prescriptions. Health-Care spending in the U.S. rose a stunning 9.3% in 2002, which is the greatest increase for the past eleven years. (Steele 46) Many pharmaceutical companies are robbing their clients by charging extreme rates for their products.
Per capita spending on prescription drugs in America is far greater than any other country. Kesselheim goes on to say that this is a natural result of America’s free market approach to healthcare resulting in monopolies. These healthcare monopolies are not held accountable for their high drug prices. The claims that these costs can be justified through research and development is rubbish, according to
Office, U. A. (2002). Prescription drugs: FDA oversight of direct-to-consumeradvertising has limitations (GAO-3-177). Washington, D.C.
Pharmacy is a booming field when it comes to medicine, but it certainly has controversial issues such as compounding drugs. While the practice of making drugs customized to a patient seems ethical, there are problems that come along with it. Drug compounding was the norm in the past, but over time consumers began to see issues with it. Drug compounding still occurs to this day because some patients do need medicine specifically tailored to their needs. Compounding has also been the focus of recent disasters, some of which occurred less than two years ago. Whatever side one may take on this issue, it is clear that compounding medicine will be a polarizing issue for years to come.
In recent years’ health reform has been a driving force in the United States political system. If you watch the news, you will understand how citizens, the government, or the economy are or might be affected by some sort of change in medical regulation. One of these hot topic issues is the cost of prescription drugs. Every major drug market besides the United States regulates the price of drugs in some way (Abbott and Vernon). By the United States not doing so, many believe it opens consumers up to being exploited by large pharmaceutical companies.
The Pharmaceutical Industry goals is to get as much profit incentive as possible through clinical trials, social networking, ads driving in a social movement in the demand for consumer goods. Patients have become more knowledgeable, demanding, and critical of medical care (Williams & Calman 1996). The internet has facilitated consumer involvement by offering easily accessible health-related information and providing a method for communication among like minded individuals (Hardey 2001). Medicalization from an analytical stand point is facilitated by the development of innovative technologies, consumer demands and the emergence of new medical markets in the hands of pharmaceutical enterprises. When medical products, services, or treatments are promoted to consumers to improve their health, appearance, or well-being, we see the development of medical market (Conrad & Leiter 2004).The race for cure, a Breast Cancer Awareness organization has been developed into a commodity for selling pink ribbons and bands. The awareness of Breast cancer is not being fully recognized by those who may not be knowledgeable of the treatments, mammograms, screening and essentially anything cancer related if the focus is on the marketing of products. Oftentimes, these corporations, sponsors, pharmaceuticals are concern with capitalizing on the health of the patience through empowering ads, to maximizing profits. Through private and
Pharmacists often work together in a team with other healthcare professional like physicians and nurses. In the process, pharmacists will give advice to them on the selection of medication, by providing the evidences based on the dosage form, the side effects and possible interaction with food of the medication. On the other hand, pharmacists also take part in research and clinical studies. Recently, pharmacists are recruited to conduct pharmacy-based research in pharmacies. (Swanson, 2005)